These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28845597)

  • 1. Pubertal growth and adult height in relation to breast cancer risk in African American women.
    Bertrand KA; Gerlovin H; Bethea TN; Palmer JR
    Int J Cancer; 2017 Dec; 141(12):2462-2470. PubMed ID: 28845597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
    Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
    J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women.
    Barber LE; Zirpoli GR; Cozier YC; Rosenberg L; Petrick JL; Bertrand KA; Palmer JR
    Breast Cancer Res; 2021 Nov; 23(1):108. PubMed ID: 34809694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin use and risk of breast cancer in African American women.
    Bertrand KA; Bethea TN; Gerlovin H; Coogan PF; Barber L; Rosenberg L; Palmer JR
    Breast Cancer Res; 2020 Sep; 22(1):96. PubMed ID: 32887656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study.
    Ritte R; Lukanova A; Tjønneland A; Olsen A; Overvad K; Mesrine S; Fagherazzi G; Dossus L; Teucher B; Steindorf K; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Grioni S; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Buckland G; Molina-Montes E; Chirlaque MD; Ardanaz E; Amiano P; Bueno-de-Mesquita B; van Duijnhoven F; van Gils CH; Peeters PH; Wareham N; Khaw KT; Key TJ; Travis RC; Krum-Hansen S; Gram IT; Lund E; Sund M; Andersson A; Romieu I; Rinaldi S; McCormack V; Riboli E; Kaaks R
    Int J Cancer; 2013 Jun; 132(11):2619-29. PubMed ID: 23090881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?
    Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR
    Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.
    Bertrand KA; Bethea TN; Rosenberg L; Bandera EV; Khoury T; Troester MA; Ambrosone CB; Palmer JR
    Breast; 2020 Feb; 49():108-114. PubMed ID: 31786415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type II Diabetes and Incidence of Estrogen Receptor Negative Breast Cancer in African American Women.
    Palmer JR; Castro-Webb N; Bertrand K; Bethea TN; Denis GV
    Cancer Res; 2017 Nov; 77(22):6462-6469. PubMed ID: 29141994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women.
    Bertrand KA; Bethea TN; Adams-Campbell LL; Rosenberg L; Palmer JR
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):270-277. PubMed ID: 27756774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American Women.
    Ambrosone CB; Zirpoli G; Hong CC; Yao S; Troester MA; Bandera EV; Schedin P; Bethea TN; Borges V; Park SY; Chandra D; Rosenberg L; Kolonel LN; Olshan AF; Palmer JR
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26085483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pubertal timing and breast cancer risk in the Sister Study cohort.
    Goldberg M; D'Aloisio AA; O'Brien KM; Zhao S; Sandler DP
    Breast Cancer Res; 2020 Oct; 22(1):112. PubMed ID: 33109223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and perinatal factors and incidence of breast cancer in the Black Women's Health Study.
    Barber LE; Bertrand KA; Rosenberg L; Battaglia TA; Palmer JR
    Cancer Causes Control; 2019 Jan; 30(1):87-95. PubMed ID: 30498869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between age maximum height is attained, age at menarche, and age at first full-term birth and breast cancer risk.
    Li CI; Littman AJ; White E
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2144-9. PubMed ID: 17932363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
    Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
    Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity and lactation in relation to estrogen receptor negative breast cancer in African American women.
    Palmer JR; Boggs DA; Wise LA; Ambrosone CB; Adams-Campbell LL; Rosenberg L
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1883-91. PubMed ID: 21846820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
    Ritte R; Tikk K; Lukanova A; Tjønneland A; Olsen A; Overvad K; Dossus L; Fournier A; Clavel-Chapelon F; Grote V; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Berrino F; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Buckland G; Molina-Montes E; Chirlaque MD; Ardanaz E; Amiano P; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Wareham N; Khaw KT; Key TJ; Travis RC; Weiderpass E; Dumeaux V; Lund E; Sund M; Andersson A; Romieu I; Rinaldi S; Vineis P; Merritt MA; Riboli E; Kaaks R
    BMC Cancer; 2013 Dec; 13():584. PubMed ID: 24321460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between menstrual factors and breast cancer according to estrogen receptor status of tumor: a case-control study in African-American women.
    Zhu K; Beiler J; Hunter S; Payne-Wilks K; Roland CL; Forbes DS; Chinchilli VM; Bernard LJ; Jacobsen KH; Levine RS
    Ethn Dis; 2002; 12(4):S3-23-9. PubMed ID: 12477150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study.
    Ambrosone CB; Zirpoli G; Ruszczyk M; Shankar J; Hong CC; McIlwain D; Roberts M; Yao S; McCann SE; Ciupak G; Hwang H; Khoury T; Jandorf L; Bovbjerg DH; Pawlish K; Bandera EV
    Cancer Causes Control; 2014 Feb; 25(2):259-65. PubMed ID: 24249438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between estrogen receptor-negative breast cancer and timing of reproductive events differ between African American and European American women.
    Ambrosone CB; Zirpoli GR; Bovbjerg DH; Shankar J; Hong CC; McCann SE; Ruszczyk M; Khoury T; Yao S; Ciupak GL; Jandorf L; Pawlish KS; Bandera EV
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1115-20. PubMed ID: 24718280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.